Amarin Corp PLC Files 8-K on Officer/Director Changes

Ticker: AMRN · Form: 8-K · Filed: Oct 22, 2025 · CIK: 897448

Amarin Corp PLC\UK 8-K Filing Summary
FieldDetail
CompanyAmarin Corp PLC\UK (AMRN)
Form Type8-K
Filed DateOct 22, 2025
Risk Levelmedium
Pages3
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: management-change, corporate-governance, filing

Related Tickers: AMRN

TL;DR

AMRN 8-K filed: Director/officer changes and compensation details reported.

AI Summary

Amarin Corporation plc filed an 8-K on October 22, 2025, reporting events as of October 17, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.

Why It Matters

Changes in corporate leadership and officer compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in key personnel and compensation arrangements can introduce uncertainty regarding future strategic direction and operational stability.

Key Players & Entities

  • Amarin Corporation plc (company) — Registrant
  • October 17, 2025 (date) — Earliest event reported
  • October 22, 2025 (date) — Date of report

FAQ

What specific roles have seen changes in directors or officers?

The filing indicates changes related to the departure of directors or certain officers, and the appointment of certain officers, but does not specify the exact roles within this 8-K header.

Are there any details on new director appointments?

Yes, the filing explicitly mentions the 'Election of Directors' as a reported item.

What type of compensatory arrangements are being reported?

The filing notes 'Compensatory Arrangements of Certain Officers' as a subject of the report, but specific details are not provided in the header.

When was the earliest event reported in this filing?

The earliest event reported was on October 17, 2025.

What is the primary business of Amarin Corporation plc?

Amarin Corporation plc is in the 'Pharmaceutical Preparations' industry, SIC code 2834.

Filing Stats: 767 words · 3 min read · ~3 pages · Grade level 12.4 · Accepted 2025-10-22 17:00:31

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated February 25, 2022* 10.2 First Amendment to the Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated July 17, 2023* 10.3 Second Amendment to the Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated October 6, 2025* 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Management contract or compensatory plan or arrangement. Certain personal information in this exhibit has been omitted in accordance with Regulation S-K Item 601(a)(6). * * *

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2025 Amarin Corporation plc By: /s/ Aaron Berg Aaron Berg President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.